戻る
Amgen Shares Advance Following EMA Recommendation for Uplizna
戻る
株式ニュース
テーマ
Amgen Shares Advance Following EMA Recommendation for Uplizna
ARKポートフォリオ
Amgen Shares Advance Following EMA Recommendation for Uplizna
Edgen Stock
·
Sep 20 2025, 18:33
共有先
共有先
リンクをコピー
ソース：
[1] EMA Backs Amgen Drug For Rare Autoimmune Disorder
[2] Amgen's Uplizna: A Regulatory and Commercial Breakthrough in IgG4-Related Disease
[3] Why Amgen (AMGN) Stock Is Trading Up Today - StockStory
Edgen Stock·Sep 20 2025, 18:33Edgen Stock·Sep 20 2025, 18:33
Edgen Stock·Sep 20 2025, 18:33